Levast Benoît, Barblu Lucie, Coutu Mathieu, Prévost Jérémie, Brassard Nathalie, Peres Adam, Stegen Camille, Madrenas Joaquín, Kaufmann Daniel E, Finzi Andrés
Department of Microbiology and Immunology, and Microbiome and Disease Tolerance Centre, McGill University, Montreal, Quebec, Canada.
Centre de Recherche du Centre Hospitalier Universitaire de Montréal, Montreal, Quebec, Canada.
PLoS One. 2017 Mar 27;12(3):e0174550. doi: 10.1371/journal.pone.0174550. eCollection 2017.
The first step of HIV infection involves the interaction of the gp120 envelope glycoprotein to its receptor CD4, mainly expressed on CD4+ T cells. Besides its role on HIV-1 entry, the gp120 has been shown to be involved in the production of IL-1, IL-6, CCL20 and other innate response cytokines by bystander, uninfected CD4+ T cells and monocytes. However, the gp120 determinants involved in these functions are not completely understood. Whether signalling leading to cytokine production is due to CD4 or other receptors is still unclear. Enhanced chemokine receptor binding and subsequent clustering receptors may lead to cytokine production. By using a comprehensive panel of gp120 mutants, here we show that CD4 binding is mandatory for cytokine outburst in monocytes. Our data suggest that targeting monocytes in HIV-infected patients might decrease systemic inflammation and the potential tissue injury associated with the production of inflammatory cytokines. Understanding how gp120 mediates a cytokine burst in monocytes might help develop new approaches to improve the chronic inflammation that persists in these patients despite effective suppression of viremia by antiretroviral therapy.
HIV感染的第一步涉及包膜糖蛋白gp120与其受体CD4的相互作用,CD4主要表达于CD4+T细胞上。除了在HIV-1进入过程中的作用外,gp120已被证明可通过旁观者未感染的CD4+T细胞和单核细胞参与IL-1、IL-6、CCL20和其他先天反应细胞因子的产生。然而,参与这些功能的gp120决定簇尚未完全明确。导致细胞因子产生的信号传导是由于CD4还是其他受体仍不清楚。趋化因子受体结合增强及随后的受体聚集可能导致细胞因子产生。通过使用一组全面的gp120突变体,我们在此表明,CD4结合对于单核细胞中的细胞因子爆发是必需的。我们的数据表明,针对HIV感染患者的单核细胞可能会降低全身炎症以及与炎性细胞因子产生相关的潜在组织损伤。了解gp120如何介导单核细胞中的细胞因子爆发可能有助于开发新方法,以改善这些患者尽管通过抗逆转录病毒疗法有效抑制病毒血症但仍持续存在的慢性炎症。